Intravenous busulfan with thiotepa and cyclophosphamide (TBC) as a conditioning regimen for autologous progenitor cell transplantation (PCT) in patients with multiple myeloma (MM).

被引：0
|
作者：
Anagnostopoulos, A [1 ]
Aleman, A [1 ]
Weber, D [1 ]
Andersson, B [1 ]
Braunschweig, I [1 ]
Claxton, D [1 ]
Donato, M [1 ]
Khouri, I [1 ]
Anderlini, P [1 ]
Korbling, M [1 ]
Gajewski, J [1 ]
Alexanian, R [1 ]
Champlin, R [1 ]
Giralt, S [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1497
引用
下载
收藏
页码：335A / 335A
页数：1
相关论文
共 50 条
  • [41] Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma
    Grisariu, Sigal
    Shapira, Michael Y.
    Or, Reuven
    Avni, Batia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 272 - 279
  • [42] A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma
    Radhakrishnan, Sabarinath, V
    Boyer, Michael
    Sherwin, Catherine M.
    Zangari, Maurizio
    Tricot, Guido
    CELL TRANSPLANTATION, 2019, 28 (12) : 1624 - 1631
  • [43] A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma
    Einsele, H
    Bamberg, M
    Budach, W
    Schmidberger, H
    Hess, CF
    Wörmann, B
    Meisner, C
    Straka, C
    Hebart, H
    Trümper, L
    Kröger, N
    Zander, AR
    Hegewisch-Becker, S
    Hossfeld, DK
    Schmidt, H
    Müller, P
    Schlimok, G
    Hertenstein, B
    Peest, D
    Metzner, B
    Frickhofen, N
    Kanz, L
    Bensinger, WI
    BONE MARROW TRANSPLANTATION, 2003, 32 (06) : 593 - 599
  • [44] A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma
    H Einsele
    M Bamberg
    W Budach
    H Schmidberger
    C F Hess
    B Wörmann
    C Meisner
    C Straka
    H Hebart
    L Trümper
    N Kröger
    A R Zander
    S Hegewisch-Becker
    D K Hossfeld
    H Schmidt
    P Müller
    G Schlimok
    B Hertenstein
    D Peest
    B Metzner
    N Frickhofen
    L Kanz
    W I Bensinger
    Bone Marrow Transplantation, 2003, 32 : 593 - 599
  • [45] BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN FOR AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
    ALEGRE, A
    LAMANA, M
    ARRANZ, R
    FERNANDEZVILLALTA, MJ
    TOMAS, JF
    FIGUERA, A
    CAMARA, R
    STEEGMAN, JL
    CASADO, F
    REQUENA, MJ
    PLANAS, JL
    VAZQUEZ, L
    GRANDA, A
    FERNANDEZRANADA, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 380 - 386
  • [46] TBC (thiotepa, busulfan, cyclophosphamide) conditioning for second autologous transplants in patients with primary mediastinal B cell lymphoma may induce durable remissions.
    Smith, SM
    Levitan, D
    Zimmerman, T
    Welborne, K
    Villegas, C
    van Besien, K
    BLOOD, 2003, 102 (11) : 489B - 489B
  • [47] Phase 2 Study Using Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma; Final Analysis (KMM150)
    Lee, Je-Jung
    Jung, Sung-Hoon
    Kim, Kihyun
    Kim, Jin Seok
    Eom, Hyeon Seok
    Min, Chang Ki
    Moon, Joon Ho
    Sohn, Sang Kyun
    Park, Yong
    Lee, Ho Sup
    Kim, Sung-Hyun
    Shin, Ho-Jin
    Joo, Young Don
    Yoon, Sung-Soo
    Park, Seong Kyu
    Kwak, Jae-Young
    Kang, Hye Jin
    Choi, Yunsuk
    Mun, Yeung-Chul
    Lee, Jae Hoon
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E73 - E74
  • [48] Efficacy of Thiotepa-Busulfan-Cyclophosphamide (TBC) Conditioning and Autologous Transplantation As Consolidation for Systemic Non-Hodgkin Lymphoma with Synchronous CNS Involvement
    Brunner, Andrew M.
    Jacobsen, Eric
    Brown, Jennifer R.
    Fisher, David C.
    McAfee, Steven L.
    Soiffer, Robert J.
    Armand, Philippe
    Chen, Yi-Bin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S120 - S121
  • [49] Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma
    Anagnostopoulos, A
    Aleman, A
    Ayers, G
    Donato, M
    Champlin, R
    Weber, D
    Alexanian, R
    Giralt, S
    CANCER, 2004, 100 (12) : 2607 - 2612
  • [50] Busulfan plus melfalan in autologous blood stem cell transplantation for multiple myeloma (MM).
    Massumoto, C
    Mizukami, S
    Campos, MF
    Silva, L
    Graziani, S
    BLOOD, 1998, 92 (10) : 324B - 324B
12345